Epstein-Barr Virus LF2 Protein Regulates Viral Replication by Altering Rta Subcellular Localization

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Virology

• Publication date

  2010-07-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.00573-10PMID 20631124PMCID PMC2937793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sumoylation of the Epstein-Barr Virus BZLF1 Protein Inhibits Its Transcriptional Activity and Is Regulated by the Virus-Encoded Protein Kinase

  2010cited by this paper
• Modifications of p53: competing for the lysines.

  2009cited by this paper
• Stimulus Duration and Response Time Independently Influence the Kinetics of Lytic Cycle Reactivation of Epstein-Barr Virus

  2009cited by this paper
• Early Events Associated with Infection of Epstein-Barr Virus Infection of Primary B-Cells

  2009influential reference
• SUMO association with repressor complexes, emerging routes for transcriptional control.

  2009cited by this paper
• Detection of protein SUMOylation in vivo

  2009cited by this paper
• Protein structure prediction on the Web: a case study using the Phyre server

  2009cited by this paper
• AP-1 homolog BZLF1 of Epstein–Barr virus has two essential functions dependent on the epigenetic state of the viral genome

  2009cited by this paper
• Methylation-Dependent Binding of the Epstein-Barr Virus BZLF1 Protein to Viral Promoters

  2009cited by this paper
• Negative Autoregulation of Epstein-Barr Virus (EBV) Replicative Gene Expression by EBV SM Protein

  2009cited by this paper
• The Epstein-Barr Virus LF2 Protein Inhibits Viral Replication

  2008cited by this paper
• Activation of the ERK signal transduction pathway by Epstein-Barr virus immediate-early protein Rta.

  2008cited by this paper
• Epstein-Barr Virus LF2: an Antagonist to Type I Interferon

  2008cited by this paper
• Lytic cycle switches of oncogenic human gammaherpesviruses.

  2007cited by this paper
• Epstein–Barr virus and virus human protein interaction maps

  2007cited by this paper
• C-terminal modifications regulate MDM2 dissociation and nuclear export of p53

  2007cited by this paper
• Detection of modification by ubiquitin-like proteins.

  2006cited by this paper
• Spectrum of Epstein-Barr virus-associated diseases.

  2006cited by this paper
• Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus.

  2006cited by this paper
• Regulation of the expression of the Epstein-Barr virus early gene BFRF1.

  2006cited by this paper
• Something about SUMO inhibits transcription.

  2005cited by this paper
• Regulating Inducible Transcription Through Controlled Localization

  2005cited by this paper
• New Genes from Old: Redeployment of dUTPase by Herpesviruses

  2005cited by this paper
• Reactivation of Epstein-Barr virus can be triggered by an Rta protein mutated at the nuclear localization signal.

  2005cited by this paper
• Activation of Sp1-mediated transcription by Rta of Epstein–Barr virus via an interaction with MCAF1

  2005cited by this paper
• Virion Proteins of Kaposi's Sarcoma-Associated Herpesvirus

  2005cited by this paper
• Murine Gammaherpesvirus 68 Open Reading Frame 11 Encodes a Nonessential Virion Component

  2005cited by this paper
• Marked Variation in Response of Consensus Binding Elements for the Rta Protein of Epstein-Barr Virus

  2005cited by this paper
• Post-translational Modification of Rta of Epstein-Barr Virus by SUMO-1*

  2004cited by this paper
• The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome

  2004cited by this paper
• Proteins of purified Epstein-Barr virus.

  2004cited by this paper
• The BRRF1 Early Gene of Epstein-Barr Virus Encodes a Transcription Factor That Enhances Induction of Lytic Infection by BRLF1

  2004cited by this paper
• Signaling to NF-kappaB.

  2004cited by this paper
• Phosphorylation of Epstein-Barr Virus ZEBRA Protein at Its Casein Kinase 2 Sites Mediates Its Ability To Repress Activation of a Viral Lytic Cycle Late Gene by Rta

  2004cited by this paper
• Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes

  2004cited by this paper
• Lytic Induction Therapy for Epstein-Barr Virus-Positive B-Cell Lymphomas

  2004cited by this paper
• How the ubiquitin–proteasome system controls transcription

  2003cited by this paper
• Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta.

  2003cited by this paper
• Modification with SUMO

  2003cited by this paper
• Epstein-Barr Virus Nuclear Protein EBNA3A Is Critical for Maintaining Lymphoblastoid Cell Line Growth

  2003cited by this paper
• Regulation of Epstein-Barr virus lytic cycle activation in malignant and nonmalignant disease.

  2002cited by this paper
• Use of Adenovirus Vectors Expressing Epstein-Barr Virus (EBV) Immediate-Early Protein BZLF1 or BRLF1 To Treat EBV-Positive Tumors

  2002cited by this paper
• Epstein-Barr Virus Immediate-Early Protein BRLF1 Induces the Lytic Form of Viral Replication through a Mechanism Involving Phosphatidylinositol-3 Kinase Activation

  2001cited by this paper
• Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot

  2001cited by this paper
• Autostimulation of the Epstein-Barr Virus BRLF1 Promoter Is Mediated through Consensus Sp1 and Sp3 Binding Sites

  2001cited by this paper
• Epstein-Barr Virus Immediate-Early Protein BZLF1 Is SUMO-1 Modified and Disrupts Promyelocytic Leukemia Bodies

  2001cited by this paper
• Induction of Epstein-Barr Virus Kinases To Sensitize Tumor Cells to Nucleoside Analogues

  2001cited by this paper
• Regulation of Transcriptional Activation Domain Function by Ubiquitin

  2001cited by this paper
• The Epstein–Barr virus lytic program is controlled by the co‐operative functions of two transactivators

  2000cited by this paper
• Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis.

  2000cited by this paper
• The transcriptional role of PML and the nuclear body

  2000cited by this paper
• Epstein-Barr Virus Immediate-Early Proteins BZLF1 and BRLF1 Activate the ATF2 Transcription Factor by Increasing the Levels of Phosphorylated p38 and c-Jun N-Terminal Kinases

  2000cited by this paper
• Role of the Epstein-Barr Virus Rta Protein in Activation of Distinct Classes of Viral Lytic Cycle Genes

  1999cited by this paper
• Characterization of the Epstein-Barr virus BALF2 promoter.

  1999cited by this paper
• The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes

  1998cited by this paper
• Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency

  1997cited by this paper
• Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.

  1997cited by this paper
• Epstein-Barr virus and its replication

  1996cited by this paper
• Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.

  1996cited by this paper
• Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F

  1996cited by this paper
• Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R.

  1994cited by this paper
• The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.

  1994cited by this paper
• Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.

  1993cited by this paper
• Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promoter

  1992cited by this paper
• The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16

  1992cited by this paper
• Regulation of the Epstein-Barr virus DNA polymerase gene

  1992cited by this paper
• Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.

  1991cited by this paper
• Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activation.

  1991cited by this paper
• An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators

  1990cited by this paper
• The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein.

  1990cited by this paper
• Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region.

  1990cited by this paper
• The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.

  1989cited by this paper
• The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators

  1989cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper
• DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative.

  1980cited by this paper

• Establishing a Risk Prediction Model for Nasopharyngeal Carcinoma Based on Anti-BNLF2b Serological Biomarkers: A Retrospective Study

  2025cites this paper
• Prospective evaluation of the relevance of Epstein–Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adults

  2024cites this paper
• An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation

  2023cites this paper
• Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1

  2023cites this paper
• Comparative analysis of the humoral immune response to the EBV proteome across EBV-related malignancies.

  2023cites this paper
• Viral dUTPases: Modulators of Innate Immunity

  2022cites this paper
• Functional diversity: update of the posttranslational modification of Epstein–Barr virus coding proteins

  2022cites this paper
• Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma

  2021cites this paper
• Reactivation of Epstein-Barr Virus by HIF-1α Requires p53

  2020cites this paper
• Evolutionary effects of the AID/APOBEC family of mutagenic enzymes on human gamma-herpesviruses

  2019cites this paper
• CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms

  2018cites this paper
• Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma

  2018cites this paper
• Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

  2018cites this paper
• Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter

  2017cites this paper
• Characterization of the subcellular localization of Epstein-Barr virus encoded proteins in live cells

  2017cites this paper
• TRIM5α Promotes Ubiquitination of Rta from Epstein–Barr Virus to Attenuate Lytic Progression

  2017cites this paper
• Title: Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan

  2017cites this paper
• Epstein-Barr Virus

  2017cites this paper
• Viral Interplay with the Host Sumoylation System

  2016cites this paper
• Fourth Edition

  2016cites this paper
• Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis

  2016cites this paper
• Transcriptional activation of Epstein-Barr virus BRLF1 by USF1 and Rta.

  2015cites this paper
• RanBPM regulates Zta-mediated transcriptional activity in Epstein-Barr virus.

  2015cites this paper
• Epstein Barr Virus Volume 2

  2015cites this paper
• Epstein-Barr Virus Lytic Cycle Reactivation.

  2015cites this paper
• Epstein-Barr Virus Utilizes Ikaros in Regulating Its Latent-lytic Switch in 2 B Cells

  2014cites this paper
• Potential antiviral lignans from the roots of Saururus chinensis with activity against Epstein-Barr virus lytic replication.

  2014cites this paper
• Epstein-Barr Virus Utilizes Ikaros in Regulating Its Latent-Lytic Switch in B Cells

  2014cites this paper
• Role of RNF 4 in the ubiquitination of Rta of Epstein-Barr virus

  2013cites this paper
• Role of RNF4 in the Ubiquitination of Rta of Epstein-Barr Virus*

  2013influential citation
• Role of TAF4 in Transcriptional Activation by Rta of Epstein-Barr Virus

  2013cites this paper
• Genome-Wide Analysis of Epstein-Barr Virus Rta DNA Binding

  2012influential citation
• Epstein-Barr Virus Transcription Activator R Upregulates BARF1 Expression by Direct Binding to Its Promoter, Independent of Methylation

  2012cites this paper
• SUMO Binding by the Epstein-Barr Virus Protein Kinase BGLF4 Is Crucial for BGLF4 Function

  2012cites this paper
• Virus Rta DNA Binding Genome-Wide Analysis of Epstein-Barr

  2012cites this paper
• Regulation of the nucleocytoplasmic trafficking of viral and cellular proteins by ubiquitin and small ubiquitin‐related modifiers

  2011cites this paper
• Hypoxia-inducible factor-1 α plays roles in Epstein-Barr virus ’ s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF 1 gene promoter

  year unknowncites this paper